Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Net Income towards Common Stockholders (2023 - 2025)

Fractyl Health (GUTS) has disclosed Net Income towards Common Stockholders for 3 consecutive years, with -$45.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 96.79% year-over-year to -$45.6 million, compared with a TTM value of -$122.2 million through Sep 2025, down 77.17%, and an annual FY2024 reading of -$70.4 million, up 25.29% over the prior year.
  • Net Income towards Common Stockholders was -$45.6 million for Q3 2025 at Fractyl Health, down from -$27.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$5.1 million in Q1 2024 and bottomed at -$45.6 million in Q3 2025.
  • Average Net Income towards Common Stockholders over 3 years is -$23.8 million, with a median of -$23.5 million recorded in 2023.
  • The sharpest move saw Net Income towards Common Stockholders surged 68.71% in 2024, then tumbled 369.16% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$23.5 million in 2023, then dropped by 6.21% to -$25.0 million in 2024, then crashed by 82.63% to -$45.6 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for GUTS at -$45.6 million in Q3 2025, -$27.9 million in Q2 2025, and -$23.7 million in Q1 2025.